Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
about
A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderlySynthetic Nanoparticles for Vaccines and ImmunotherapyMicro- and Nanosized Particles in Nasal Mucosa: A Pilot StudyMolecular adjuvant interleukin-33 enhances the antifertility effect of Lagurus lagurus zona pellucida 3 DNA vaccine administered by the mucosal routeTransferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen.The Role of the Notch Signal Pathway in Mucosal Cell Metaplasia in Mouse Acute Otitis Media.Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticlesTroA of Streptococcus suis is required for manganese acquisition and full virulence.Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.Non-invasive administration of biodegradable nano-carrier vaccines.Chitosan nanoparticles: a survey of preparation methods.Chitosan-based delivery systems for mucosal vaccines.Cationic polymers and their therapeutic potential.Messenger RNA (mRNA) nanoparticle tumour vaccinationNanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.Immune response and protective efficacy of S9 ribosomal protein of Streptococcus pneumoniae in a model of sepsis.Recent developments in nanocarrier-aided mucosal vaccination.Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice.Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance.Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.Maternal Glucocorticoid Elevation and Associated Fetal Thymocyte Apoptosis are Involved in Immune Disorders of Prenatal Caffeine Exposed Offspring Mice.Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration.Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.Therapeutic efficacies of chitosan against Pneumocystis pneumonia of immunosuppressed rat.
P2860
Q28084760-43B5793E-499B-4AAA-8691-1AF94B7D3665Q28085375-199D2DAA-349D-4BA2-B7A8-42BF65BD7BFAQ28648493-D416DEA5-E04C-4286-B3F6-0B32A6FDA255Q28658606-523A99A6-CF3C-437F-966C-EE96011BB12EQ30468622-C0E4C522-733B-4815-973D-DE6B648453EBQ33870627-5236CDCF-DD74-4FCC-BC44-15777A4A078FQ34391647-7C383E19-BD24-42AF-A7C3-52BDC7864B93Q34535130-948D1BCA-F1B1-4250-ACEA-48E3B14C73CBQ34661842-70E5BEBF-6664-450D-8D2B-AB0FABE25E05Q35274494-4E30BB87-B950-4948-B433-DB4F12466478Q35491580-54307EC1-BE2B-4F78-87E0-643899B4EBBFQ35878909-3964C43C-5584-47D6-81E2-88183FBDBF44Q36582241-F8137CE1-1ADF-4B38-AD0A-50FAE30D2EE1Q36893661-B016AF8B-7BBD-42B6-A545-6CA944330D50Q37473416-3832C7E6-8EAF-4020-9D5A-4601BD73E65FQ37596856-8A317EEF-46EC-4971-B73E-3B88BF0EE19FQ37980520-2E9378A5-38F8-4287-A2E5-32A4D4D32926Q38019583-CFA37F6D-DE27-4618-9939-B60BC40B566BQ38033969-D0BD31B4-BF8B-4C3A-959D-CBF02CE8A379Q38218147-37156A15-D0F7-4DA8-8790-7CE101583E11Q38418305-312101DD-0127-4568-A66F-9F41360838EDQ38810516-55A8A27F-CEEA-47A9-8A5E-0D548684AC06Q39182355-87F627A2-3C8A-4316-80D9-5219086C9B0DQ39566851-018AB19F-524D-4B9E-8898-E58CCD8CB42AQ40228907-9EBA8B22-CBAA-4E25-B971-A4D68523C383Q40309267-E4848685-27B4-469D-9AC6-E31CD484E5E6Q41426532-CEF66238-E5A0-45BC-B265-EF88A31D69ACQ41559235-AF19A47A-EE50-4FAD-969A-BC9AA48CB573Q43856138-4E50A26E-43C5-45F3-B19C-61A2B2BF0DDFQ45417683-E790A166-0ECC-4699-A8A5-9621EC7DEF45Q47446657-C56384CA-F047-44DD-B207-1F46985A5DCAQ49278291-99C7020F-B00F-4146-9B89-10334D0236E5Q52602775-79083530-DEE9-4EF6-BF84-0EE713E71A93Q54209314-DC7FF4E5-82F8-4410-8FF2-A04F833EFB29Q54214626-7BEFF2B1-FA03-4FAB-A5C8-B86CBD8E781A
P2860
Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@ast
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@en
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@nl
type
label
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@ast
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@en
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@nl
prefLabel
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@ast
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@en
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@nl
P2093
P2860
P356
P1476
Intranasal vaccination with ch ...... n by Streptococcus pneumoniae.
@en
P2093
Jianghong Xu
Wenjia Dai
Xiaoyong Fan
Zhengmin Wang
Zhongming Li
P2860
P356
10.1128/CVI.00263-10
P577
2010-11-03T00:00:00Z